| ACE2 | Angiotensin converting enzyme-2 |
| ARDS | Acute respiratory distress syndrome |
| 3CLpro | 3-Chymotrypsin-like protease |
| CC50 | Half maximal cytotoxic concentration |
| COVID-19 | Coronavirus disease-2019 |
| DPP-4 | Dipeptidyl peptidase-4 |
| EC50 | Half maximal effective concentration |
| HIV | Human immunodeficiency virus |
| HMG CoA | Hydroxymethyl glutaryl coenzyme A |
| IC50 | Half maximal inhibitory concentration |
| ICU | Intensive care unit |
| LMWHs | Low molecular weight heparins |
| MERS | Middle East respiratory syndrome |
| Mpro | Main protease |
| NSPs | Nonstructural proteins |
| PLpro | Papain-like protease |
| RAAS | Renin-angiotensin-aldosterone system |
| RdRp | RNA-dependent RNA polymerase |
| rhACE2 | Recombinant human ACE2 |
| SARS-CoV-2 | Severe acute respiratory syndrome-coronavirus-2 |
| TMPRSS2 | Transmembrane protease serine 2 |
| UFH | Unfractionated heparin |